Genocea Biosciences Initiates Phase 1 Study of Vaccine Candidate Gen-004 to Prevent Infections Caused by Pneumococcus. Brennan CaruthersDecember 5, 2013 Facebook0 Twitter LinkedIn0 Reddit 0 Likes